price
XE
NASDAQ · XERS
Xeris Biopharma Holdings, Inc.
Healthcare · Biotechnology
$8.70
Up+$0.10 (+1.16%)
Updated Aug 22, 2026, 2:49 PM
SID Score
6.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.16B
- P/E ratio
- -34.21
- Dividend yield
- 0.00%
- 52-week range
- $5.25 – $9.02
- Volume
- 1.56M
- Avg. volume
- 2.44M
Price performance
XERS price history
1M range · 21 trading sessions · Daily adjusted prices
XERS closed at $8.70 after 21 trading sessions, up 4.57% for the selected period.
- Last close
- $8.70
- Period change
- +4.57%
- Period low
- $7.36
- Period high
- $8.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $8.61 | $8.81 | $8.535 | $8.70 | 1.56M |
| Aug 20, 2026 | $8.91 | $8.985 | $8.56 | $8.60 | 2M |
| Aug 19, 2026 | $8.93 | $9.02 | $8.77 | $8.78 | 2.25M |
| Aug 18, 2026 | $8.58 | $8.88 | $8.47 | $8.85 | 2.14M |
| Aug 17, 2026 | $8.45 | $8.545 | $8.2589 | $8.52 | 1.33M |
| Aug 14, 2026 | $8.33 | $8.67 | $8.25 | $8.60 | 1.37M |
| Aug 13, 2026 | $8.59 | $8.70 | $8.30 | $8.33 | 1.85M |
| Aug 12, 2026 | $8.365 | $8.52 | $8.235 | $8.49 | 1.73M |
| Aug 11, 2026 | $8.00 | $8.436 | $7.96 | $8.39 | 1.78M |
| Aug 10, 2026 | $7.96 | $8.07 | $7.80 | $7.99 | 1.62M |
| Aug 7, 2026 | $7.43 | $8.02 | $7.43 | $7.93 | 2.25M |
| Aug 6, 2026 | $7.19 | $7.435 | $7.05 | $7.36 | 3.72M |
| Aug 5, 2026 | $8.21 | $8.37 | $8.055 | $8.11 | 1.75M |
| Aug 4, 2026 | $8.13 | $8.28 | $8.04 | $8.19 | 1.84M |
| Aug 3, 2026 | $8.135 | $8.171 | $7.865 | $8.13 | 1.95M |
| Jul 31, 2026 | $8.34 | $8.405 | $7.99 | $8.08 | 1.62M |
| Jul 30, 2026 | $8.38 | $8.455 | $8.32 | $8.42 | 920.97K |
| Jul 29, 2026 | $8.23 | $8.485 | $8.23 | $8.38 | 1.19M |
| Jul 28, 2026 | $8.28 | $8.33 | $8.125 | $8.24 | 811.64K |
| Jul 27, 2026 | $8.40 | $8.465 | $8.20 | $8.21 | 873.43K |
| Jul 24, 2026 | $8.42 | $8.54 | $8.29 | $8.32 | 1.18M |
Latest XERS news
The latest Smart Investors Daily articles mentioning XERS.
Stock researchResearch & News · SEC Filings
Loading stock research…